Stockreport

Akebia Therapeutics Announces Preliminary Full-Year 2018 Financial Results and Business Highlights

Akebia Therapeutics, Inc.  (AKBA) 
Last akebia therapeutics, inc. earnings: 3/10 07:49 am Check Earnings Report
US:NASDAQ Investor Relations: ir.akebia.com/investor-relations
PDF – Substantial revenue growth opportunity for Auryxia following robust 2018 commercial performance – – First regulatory submission for vadadustat [Read more]